Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2018

Feb 14, 2018

30339_dirs_2018-02-14_6c674cdd-48dd-471e-8297-035e751b9f43.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2017-12-31

Reporting Person: FEDERICI WILLIAM J (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-11-09 Common Stock G 3400.00 $0.00 Disposed 187093.3342 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1043.00 Indirect
Common Stock 17007.00 Indirect